Wellington Management Group LLP Decreases Stake in Esperion Therapeutics, Inc. (NASDAQ:ESPR)
Wellington Management Group LLP lowered its position in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 7.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 560,276 shares of the biopharmaceutical company’s stock after selling 42,660 shares during the quarter. Wellington Management Group LLP owned […]
Wellington Management Group LLP lowered its position in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 7.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 560,276 shares of the biopharmaceutical company’s stock after selling 42,660 shares during the quarter. Wellington Management Group LLP owned […]
